ClinConnect ClinConnect Logo
Search / Trial NCT00138931

Genetics of Cardiovascular and Neuromuscular Disease

Launched by UNIVERSITY OF CHICAGO · Aug 29, 2005

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Cardiomyopathy Arrhythmia Muscular Dystrophy

ClinConnect Summary

This clinical trial is focused on understanding the genetics behind certain heart and muscle diseases, specifically cardiomyopathy (a heart condition), arrhythmias (irregular heartbeats), and muscular dystrophy (a group of diseases that weaken muscles). The researchers are looking for specific genes and mutations that may cause these conditions, as some genes can lead to both heart and muscle problems when they are changed in certain ways. By studying the DNA of patients, especially those from families where multiple members are affected, the goal is to better understand how these diseases develop.

Anyone of any age with a suspected inherited heart or muscle disorder may be eligible to participate, especially families with more than one person affected by these conditions. If someone does not have a suspected genetic condition related to the heart or muscles, they will not be included in the study. Participants can expect to provide samples for genetic testing, which could provide important insights into their health and potentially help researchers develop better treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients of all ages will be considered for the study. In particular, families with more than one affected relative will be sought.
  • Exclusion Criteria:
  • Subjects without a suspected inherited cardiovascular or neuromuscular disorder will be excluded from this study.

About University Of Chicago

The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Elizabeth McNally, MD PhD

Principal Investigator

University of Chicago

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials